Abilify Maintena 400 mg, Depot-Injektionssuspension
7680631770041
CH-63177
N05AX12
01.05.0.
1 / 3
google
Details
- Product number
- 6317702
- CPT
- -
- Packaging group
- 400 mg
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, pro vitro corresp. natrium max. 2.2 mg. Solvens (i.m.): aqua ad iniectabile pro vitro. Corresp. in solutione recenter reconstituta 200 mg pro 1 mL.
Articles (1)
Abilify Maintena 400 mg, Depot-Injektionssuspension
Injektionssuspension
400 mg
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLIM
|
- | Substance | HNIDK |
|
PRC
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Authorization holder
Lundbeck (Schweiz) AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 63177
- Drug name
- Abilify Maintena, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
- Galenic form
- PULMS
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/04/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABILIFY MAINTENA depot 400 mg set reconstitution
- Description (DE)
- ABILIFY MAINTENA Depot 400 mg Rekonstitutions-Set
- Market launch
- 01/10/2014
- Market withdrawal
- 01/05/2016
- Narcotic (BTM)
- No